# Nitroprusside for Prevention of no-Reflow in Primary Angioplasty

> **NCT00128791** · PHASE4 · TERMINATED · sponsor: **Soroka University Medical Center** · enrollment: 100 (—)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** Nitroprusside

## Key facts

- **NCT ID:** NCT00128791
- **Lead sponsor:** Soroka University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-01
- **Primary completion:** —
- **Final completion:** 2005-04
- **Target enrollment:** 100 (—)
- **Last updated:** 2007-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00128791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00128791, "Nitroprusside for Prevention of no-Reflow in Primary Angioplasty". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT00128791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*